業績

業績

2024年

原著

  1. Keisuke Suzuki, Shiho Suzuki, Yasuo Haruyama, Kei Funakoshi, Hiroaki Fujita, Hirotaka Sakuramoto, Mai Hamaguchi, Gen Kobashi, Koichi Hirata : Associations between the burdens of comorbid sleep problems, central sensitization, and headache-related disability in patients with migraine. Front Neurol. 2024 Feb 26:15:1373574. doi: 10.3389/fneur.2024.1373574. eCollection 2024. [PMID: 38601337]
  2. Keisuke Suzuki, Shiho Suzuki, Tomohiko Shiina, Yasuo Haruyama, Saro Kobayashi, Mukuto Shioda, Koichi Hirata : Real-world effectiveness of erenumab in Japanese patients with migraine. Heliyon 10(4): e26568, 2024. [PMID: 38420497]
  3. Hiroaki Fujita, Keitaro Ogaki, Tomohiko Shiina, Hirotaka Sakuramoto, Narihiro Nozawa, Keisuke Suzuki : Impact of autonomic symptoms on the clinical course of Parkinson's disease. Neurol Sci. 2024 Feb 24. doi: 10.1007/s10072-024-07422-x. Online ahead of print. [PMID: 38400889]
  4. Daisuke Tsukui, Hidehiro Takekawa, Kozue Saito, Ryuta Okabe, Akito Tanaka, Saro Kobayashi, Haruki Igarashi, Keisuke Suzuki, Hirotoshi Hamaguchi : Usefulness of "AcT ratio" in diagnosis of internal carotid artery stenosis: a multicenter, retrospective, observational study. J Med Ultrason (2001). 2024 Apr 6. doi: 10.1007/s10396-024-01409-z. Online ahead of print. [PMID: 38581557]
  5. Hatano T, Sengoku R, Nagayama H, Yanagisawa N, Yoritaka A, Suzuki K, Nishikawa N, Mukai Y, Nomura K, Yoshida N, Seki M, Matsukawa MK, Terashi H, Kimura K, Tashiro J, Hirano S, Murakami H, Joki H, Uchiyama T, Shimura H, Ogaki K, Fukae J, Tsuboi Y, Takahashi K, Yamamoto T, Kaida K, Ihara R, Kanemaru K, Kano O. Impact of Istradefylline on Levodopa Dose Escalation in Parkinson's Disease: ISTRA ADJUST PD Study, a Multicenter, Open-Label, Randomized, Parallel-Group Controlled Study. Neurol Ther. 2024 Jan 16. doi: 10.1007/s40120-023-00574-6. Epub ahead of print. [PMID: 38227133]
  6. Etsuko Awaki, Takao Takeshima, Yasuhiko Matsumori, Koichi Hirata, Naoki Miyazaki, Ryo Takemura, Satoshi Osaga, Yoshinori Tanizawa, Mika Komori : Impact of Migraine on Daily Life: Results of the Observational survey of the Epidemiology, Treatment, and Care of Migraine (OVERCOME [Japan]) Study. Neurol Ther 13(1): 165-182, 2024. [PMID: 38175489]
  7. Tsubasa Takizawa, Keiko Ihara, Narumi Watanabe, Ryo Takemura, Nobuyuki Takahashi, Naoki Miyazaki, Mamoru Shibata, Keisuke Suzuki, Noboru Imai, Norihiro Suzuki, Koichi Hirata, Takao Takeshima, Jin Nakahara : CGRP-monoclonal antibodies in Japan: insights from an online survey of physician members of the Japanese headache society. J Headache Pain 25(1): 39, 2024. [PMID: 38491415]
  8. Mika Komori, Akichika Ozeki, Yuka Tanji, Eriko Kamiki, John H Krege, Lily Qian Li, Shiho Suzuki, Mamoru Shibata, Takao Takeshima : Long-term treatment with lasmiditan in patients with migraine: post hoc analysis of treatment patterns and outcomes from the open-label extension of the CENTURION randomized trial. J Headache Pain 25;25(1): 43, 2024. [PMID: 38528476]

症例報告

  1. Keisuke Suzuki, Shiho Suzuki, Hiroaki Fujita, Hirotaka Sakuramoto, Mukuto Shioda, Koichi Hirata : Can calcitonin gene-related peptide monoclonal antibodies ameliorate writer's cramp and migraine? Neuropsychopharmacol Rep. 2024 Apr 11. doi: 10.1002/npr2.12444. Online ahead of print. [PMID: 38602109]
  2. Mukuto Shioda, Hiroaki Fujita, Hiroki Onuma, Hirotaka Sakuramoto, Mai Hamaguchi, Keisuke Suzuki : Gait instability, ophthalmoplegia, and chorea with orofacial dyskinesia in a man with anti-Ri antibodies: a case report. Front Neurol. 2024 Mar 20:15:1359781. doi: 10.3389/fneur.2024.1359781. eCollection 2024. [ PMID: 38572489]
Copyright©2019 Department of Neurology, Dokkyo Medical University All rights reserved.